Sequencing Market Size & Growth Forecast 2026–2035, By Segments (Workflow, Product & Services, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Sequencing Market size was over USD 21.89 Billion in 2025 and is likely to grow at a 21.6% CAGR between 2026 and 2035, exceeding USD 154.73 Billion by 2035. The industry revenue for 2026 is assessed at USD 26.19 billion.
Get more details on this report
Request Free Sample ReportSequencing Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 52.36% of the market in 2025, supported by advanced laboratory infrastructure, strong genomics adoption, and high sequencing activity across research, biotechnology, and clinical applications.
- Asia Pacific is forecast to grow at a 23.76% CAGR as investments in genomic capabilities, expanding laboratory networks, and broader research and healthcare adoption accelerate sequencing deployment.
Segment Momentum
- Sequencing led the workflow segment with a 59.22% share in 2025 because it is the core operational stage that drives instrument utilization, reagent consumption, and sample throughput before downstream interpretation begins.
- Services are expanding rapidly as organizations increasingly outsource specialized sequencing workflows and data-related tasks to improve flexibility, manage complexity, and access expertise without significant in-house investment.
Market Expansion Drivers
- Expanding adoption of next-generation sequencing in oncology and precision medicine driving market growth.
- Rising demand for personalized medicine and genetic testing accelerating clinical sequencing applications.
- Growth of population-scale genomics and national sequencing initiatives expanding research and diagnostics ecosystem.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key companies in the sequencing market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V (Netherlands), Oxford Nanopore Technologies plc (U.K.), BGI Genomics Co., Ltd. (China), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Eurofins Genomics GmbH (Germany), DNASTAR, Inc. (U.S.).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Clinical oncology is becoming one of the most commercially important demand centers for the sequencing market as hospitals, cancer centers, and specialty laboratories move from single-gene tests toward broader genomic profiling. Next-generation sequencing fits the treatment logic of precision medicine by identifying actionable mutations, resistance mechanisms, and tumor heterogeneity from a single workflow, which changes purchasing behavior toward higher-throughput instruments, oncology-focused panels, bioinformatics pipelines, and interpretation services. As oncologists increasingly rely on molecular evidence to guide targeted therapy selection and monitor disease progression, the sequencing market sees stronger utilization in routine care settings rather than remaining concentrated in research use alone.
Rising demand for personalized medicine and genetic testing accelerating clinical sequencing applications
As healthcare providers place greater emphasis on individualized treatment decisions, the sequencing market benefits from wider clinical use in hereditary disease screening, reproductive health, pharmacogenomics, and rare disease diagnosis. Demand is being reinforced by the practical advantage of sequencing in resolving complex cases that are difficult to address through conventional testing, prompting clinical labs to expand test menus and invest in scalable sequencing workflows. This trend also influences payer engagement, physician adoption, and laboratory standardization, all of which support market expansion by moving sequencing closer to established diagnostic pathways.
Growth of population-scale genomics and national sequencing initiatives expanding research and diagnostics ecosystem
Large genomics programs and government-backed sequencing initiatives are supporting market development by creating sustained demand for instruments, consumables, data analysis platforms, and long-term sample processing capacity. These programs do more than fund one-time research activity; they build national infrastructure, standardize genomic data practices, and expand institutional expertise that later feeds into clinical diagnostics, biobanking, and translational research. For the sequencing market, this creates a durable ecosystem effect in which public investment lowers adoption barriers for academic centers, hospitals, and reference laboratories while increasing market penetration through broader operational readiness and data-driven healthcare use cases.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding adoption of next-generation sequencing in oncology and precision medicine driving market growth | 2.60% | High | North America, Europe | High | Near Term |
| Rising demand for personalized medicine and genetic testing accelerating clinical sequencing applications | 2.30% | High | North America, Asia Pacific | High | Near Term |
| Growth of population-scale genomics and national sequencing initiatives expanding research and diagnostics ecosystem | 1.90% | High | Asia Pacific, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 52.36% share of the sequencing market in 2025, bolstered by its dense concentration of established genomics companies, advanced laboratory infrastructure, and strong integration of sequencing into research and clinical workflows. The region’s leadership is strengthened by high testing volumes across academic centers, biotechnology firms, and healthcare institutions, where access to sophisticated platforms, skilled specialists, and well-developed data analysis capabilities helps sustain steady instrument use and service demand. Broad adoption in precision medicine, oncology research, and large-scale genomic programs also keeps commercial activity concentrated in the region.
Asia Pacific is projected to expand at a 23.76% CAGR over the forecast period, with the sequencing market gaining momentum as regional healthcare systems, research institutes, and biotech ecosystems increase investment in genomic capabilities. Growth is being impelled by the practical expansion of sequencing access across emerging laboratory networks, rising use in population-scale studies and disease research, and a growing base of local and regional participants building processing and analytical capacity. As more institutions move from pilot adoption to routine deployment, market activity is accelerating across both research and applied settings.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Research Infrastructure StrengthGermany prioritizes sequencing technologies across academic research, biotechnology, and clinical laboratories. Investment in standardized genomic workflows and advanced analytical platforms supports wider adoption in healthcare and life sciences.
France 🇫🇷
Translational Genomics FocusFrance advances sequencing adoption by connecting genomic research with clinical practice in oncology and inherited disease testing. Healthcare institutions emphasize quality standards and collaborative research to enhance genomic medicine capabilities.
Italy 🇮🇹
Laboratory ModernizationItaly is modernizing sequencing laboratories with greater emphasis on molecular diagnostics, research collaboration, and workflow automation. Clinical institutions are expanding genomic testing capacity to support personalized treatment approaches across multiple specialties.
Japan 🇯🇵
Precision Healthcare IntegrationJapan incorporates sequencing technologies into precision healthcare programs, rare disease research, and oncology diagnostics. Laboratories continue improving workflow efficiency while expanding genomic testing capabilities across clinical settings.
South Korea 🇰🇷
Biotechnology Innovation HubSouth Korea strengthens the sequencing market through biotechnology innovation, precision medicine initiatives, and expanding genomic research. Companies are investing in automation and data analysis solutions to improve laboratory productivity and clinical utility.
United States 🇺🇸
Clinical Genomics ExpansionThe U.S. sequencing market continues advancing through clinical diagnostics, precision medicine, and pharmaceutical research initiatives. Healthcare providers and research organizations are increasing adoption of high-throughput platforms and bioinformatics capabilities for broader genomic applications.
Segment Leadership and Growth Trends
Sequencing Market Share (%), Workflow, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the sequencing market, Sequencing held the dominant position in 2025 with a 59.22% share, reflecting its central role in the overall workflow. This segment maintains leadership because sequence generation is the core operational step around which instrument use, reagent consumption, and sample throughput are organized. Demand continues to concentrate here as laboratories, research centers, and clinical settings depend on reliable sequencing output before any downstream interpretation can occur, keeping spending closely tied to this stage of the sequencing market.
Data Analysis is the fastest-growing workflow segment in the sequencing market as users face rising volumes of complex genomic output that require efficient interpretation, filtering, and actionable reporting. Its momentum is being encouraged by the practical need to convert raw sequencing data into usable insights at scale, which becomes more pressing as sequencing adoption expands across research and applied settings. Compared with other workflow stages, Data Analysis is gaining faster traction because the value of sequencing increasingly depends on how quickly and accurately results can be processed into decisions.
Product & Services Segment Analysis: Consumables (Largest Segment) vs Services (Fastest-Growing Segment)
In 2025, Consumables accounted for a 47.17% share of the sequencing market, making them the largest segment within product and services. Their leadership is underpinned by recurring usage patterns, since every sequencing run depends on kits, reagents, chips, and other expendable inputs that must be replenished regularly. This repeat-purchase cycle keeps demand steady across end users and gives Consumables a durable revenue base in the sequencing market.
Services are emerging as the fastest-growing segment in the sequencing market because many users need external support for specialized workflows, technical execution, and data-related requirements without building all capabilities in-house. Growth is being backed by the practical shift toward outsourcing parts of the sequencing process to improve flexibility, manage complexity, and reduce the burden of maintaining specialized expertise internally. Relative to physical product categories, Services are gaining momentum as adoption broadens among organizations seeking faster access to sequencing capabilities with lower operational commitment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Workflow | Pre-Sequencing, Sequencing, Data Analysis | Sequencing | Data Analysis |
| Product & Services | Platform, Consumables, Services, Software | Consumables | Services |
| End-use | Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Others | Academic Research | Clinical Research |
Competitive Landscape and Market Positioning
1. Illumina Inc. (U.S.)
2. Thermo Fisher Scientific Inc. (U.S.)
3. F. Hoffmann-La Roche Ltd. (Switzerland)
4. QIAGEN N.V (Netherlands)
5. Oxford Nanopore Technologies plc (U.K.)
6. BGI Genomics Co. Ltd. (China)
7. Bio-Rad Laboratories Inc. (U.S.)
8. PerkinElmer Inc. (U.S.)
9. Eurofins Genomics GmbH (Germany)
10. DNASTAR Inc. (U.S.)
The sequencing market is advancing through rapid improvements in high-throughput analysis and cost-efficient genetic decoding methods. Continuous research efforts are expanding accuracy while reducing processing time. Integration of advanced computational tools is further strengthening data interpretation capabilities. The sequencing market is increasingly central to precision medicine and large-scale biological research initiatives.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| 10x Genomics | Aug-24 | 10x Genomics launched the Atera spatial genomics platform, featuring whole-transcriptome capabilities designed for high-resolution gene expression mapping. This expansion of the company's spatial biology portfolio enhances technical capabilities for oncology and translational research, providing advanced spatial sequencing tools to support deeper insights into complex biological systems and tumor microenvironments. |
| Illumina | Aug-24 | Illumina acquired SomaLogic for approximately $425 million, integrating proteomics capabilities into its core multiomics strategy. This strategic acquisition is intended to bridge genomic and proteomic data analysis, allowing for more comprehensive biological insights and strengthening Illumina’s competitive positioning in the precision diagnostics and life science research tool markets. |
| Illumina | May-24 | Illumina commercially launched the NovaSeq X Plus, a high-throughput sequencing platform engineered to improve speed, scalability, and cost efficiency. By significantly increasing data output capacities, the system supports large-scale clinical and research sequencing initiatives, reinforcing the company's infrastructure leadership within the next-generation sequencing market. |
| Oxford Nanopore Technologies | Aug-24 | Oxford Nanopore Technologies entered a partnership with Lonza to develop a GMP-focused mRNA quality control solution. By integrating sequencing-based analysis into biopharmaceutical manufacturing workflows, the collaboration aims to standardize and accelerate regulatory-grade testing, providing a scalable solution for mRNA therapeutic quality assurance. |
| Roche | Jul-24 | Roche is advancing its sequencing-by-expansion (SBX) technology through strategic collaborations, including efforts with the Broad Institute. The development program focuses on clinical validation for high-accuracy applications like newborn screening, positioning Roche to challenge existing next-generation sequencing standards with a technology platform designed for clinical speed and diagnostic precision. |
| Ultima Genomics | May-24 | Ultima Genomics initiated the rollout of an ultra-high-throughput sequencing system designed for automated, continuous operation. The platform features flexible run configurations aimed at increasing throughput and reducing costs for germline and large-scale research applications, strengthening the company’s competitive footprint in the high-capacity genome sequencing segment. |
| Illumina | Jul-24 | Illumina partnered with NVIDIA to integrate the DRAGEN bioinformatics software into accelerated computing platforms via Illumina Connected Analytics. This collaboration enhances genomic data processing speeds, providing the computational scalability required for AI-enabled sequencing analytics in large-scale precision medicine and complex research environments. |
| Avance Biosciences | Jul-24 | Avance Biosciences established a Next-Generation Sequencing Center of Excellence in Houston to expand its contract research infrastructure. The facility is equipped to provide advanced genomic analysis and translational research services, supporting biopharmaceutical R&D efforts with high-capacity sequencing and molecular biology capabilities. |
| Illumina | Mar-23 | Illumina launched its Complete Long Read technology, enabling the generation of both long and short reads on a single sequencing instrument. This technological innovation addresses critical needs for improved genomic assembly and variant detection, marking a significant advancement in the flexibility and diagnostic utility of NGS workflows. |
| Baylor Genetics | Jun-24 | Baylor Genetics and Baylor College of Medicine inaugurated a Medical Genetics Multi-Omics Laboratory to centralize integrated genetic testing. The facility utilizes a multi-omic approach, combining advanced sequencing with molecular diagnostics to improve diagnostic yield for rare diseases and accelerate research in precision medicine. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Sequencing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Sequencing Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the sequencing market?
What is the projected value of the sequencing industry by 2035?
How is oncology-driven precision medicine reshaping purchasing priorities in the sequencing market?
Why are national and population-scale genomics initiatives becoming a key growth engine for the sequencing market?
Why is Sequencing the largest workflow segment in the sequencing market?
Why are Services the fastest-growing product and services segment in the sequencing market?
What makes North America the leading region in the sequencing market?
Why is Asia Pacific the fastest-growing sequencing market?
Who are the leading players in the sequencing landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization